The unmet need in the elderly: Designing new influenza vaccines for older adults

Vaccine

Volumn 23, Issue SUPPL. 1, 2005, Pages S10-

  McElhaney, Janet E ^a  

^a UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

Author keywords

Elderly; Immune response; Influenza

Indexed keywords

CYTOKINE; GRANZYME B; INFLUENZA VACCINE; ANTIVIRUS AGENT;

AGING; APOPTOSIS; ARTICLE; CELLULAR IMMUNITY; CYTOKINE PRODUCTION; CYTOTOXIC T LYMPHOCYTE; DEATH; DISABILITY; DISEASE SEVERITY; GERIATRIC CARE; HEALTH CARE; HEALTH CARE COST; HEALTH CARE SYSTEM; HEALTH PROGRAM; HEART FAILURE; HOSPITALIZATION; HUMAN; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOPATHOGENESIS; INFLUENZA; INFLUENZA VACCINATION; INNATE IMMUNITY; LUNG PARENCHYMA; MEMORY CELL; MORTALITY; PNEUMONIA; PRIORITY JOURNAL; PROTEIN FUNCTION; RESPIRATORY TRACT DISEASE; STROKE; T LYMPHOCYTE ACTIVATION; TH1 CELL; TH2 CELL; AGED; GERIATRIC ASSESSMENT; IMMUNOLOGY; RESPIRATORY TRACT INFECTION; VACCINATION;

AGED; AGED, 80 AND OVER; AGING; ANTIVIRAL AGENTS; GERIATRIC ASSESSMENT; HUMANS; INFLUENZA VACCINES; INFLUENZA, HUMAN; RESPIRATORY TRACT INFECTIONS; VACCINATION;

EID: 22544459957     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2005.04.019     Document Type: Article

References (131)

1. T.A. Reichert, L. Simonsen, A. Sharma, S.A. Pardo, D.S. Fedson, and M.A. Miller Influenza and the winter increase in mortality in the United States, 1959-1999 Am J Epidemiol 160 2004 492 502
2. D.M. Fleming, and A.J. Elliot The impact of influenza on the health and health care utilisation of elderly people Vaccine 23S1 2005 S1/1 S1/9
3. W.W. Thompson, D.K. Shay, and E. Weintraub Mortality associated with influenza and respiratory syncytial virus in the United States JAMA 289 2003 179 186
4. W.P. Glezen, S.B. Greenberg, R.L. Atmar, P.A. Piedra, and R.B. Couch Impact of respiratory virus infections on persons with chronic underlying conditions JAMA 283 2000 499 505
5. L. Simonsen, K. Fukuda, L.B. Schonberger, and N.J. Cox The impact of influenza epidemics on hospitalizations J Infect Dis 181 2000 831 837
6. W.W. Thompson, D.K. Shay, and E. Weintraub Influenza-associated hospitalizations in the United States JAMA 292 2004 1333 1340
7. L. Ferrucci, J.M. Guralnik, M. Pahor, M.C. Corti, and R.J. Havlik Hospital diagnoses, medicare charges, and nursing home admissions in the year when older persons become severely disabled [see comments] JAMA 277 1997 728 734
8. T.M. Govaert, M.J. Sprenger, G.J. Dinant, K. Aretz, N. Masurel, and J.A. Knottnerus Immune response to influenza vaccination of elderly people. A randomized double-blind placebo-controlled trial Vaccine 12 1994 1185 1189
9. K.L. Nichol, J. Nordin, J. Mullooly, R. Lask, K. Fillbrandt, and M. Iwane Influenza vaccination and reduction in hospitalizations for cardiac disease and stroke among the elderly N Engl J Med 348 2003 1322 1332
10. K.L. Nichol The efficacy, effectiveness and cost-effectiveness of inactivated influenza virus vaccines Vaccine 21 2003 1769 1775
11. K.L. Nichol, K.L. Margolis, J. Wuorenma, and T. Von Sternberg The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community N Engl J Med 331 1994 778 784
12. T. Vu, S. Farish, M. Jenkins, and H. Kelly A meta-analysis of effectiveness of influenza vaccine in persons aged 65 years and over living in the community Vaccine 20 2002 1831 1836
13. E. Hak, J. Nordin, and F. Wei Influence of high-risk medical conditions on the effectiveness of influenza vaccination among elderly members of 3 large managed-care organizations Clin Infect Dis 35 2002 370 377 [Epub 2002 July 19]
14. E. Hak, F. Wei, J. Nordin, J. Mullooly, S. Poblete, and K.L. Nichol Development and validation of a clinical prediction rule for hospitalization due to pneumonia or influenza or death during influenza epidemics among community-dwelling elderly persons J Infect Dis 189 2004 450 458 [Epub 2004 January 23]
15. J. Potter, D.J. Stott, and M.A. Roberts Influenza vaccination of health care workers in long-term-care hospitals reduces the mortality of elderly patients J Infect Dis 175 1997 1 6
16. G.J. Gorse, T.Z. O'Connor, and S.L. Young Efficacy trial of live, cold-adapted and inactivated influenza virus vaccines in older adults with chronic obstructive pulmonary disease: a VA cooperative study Vaccine 21 2003 2133 2144
17. G.J. Gorse, T.Z. O'Connor, and F.K. Newman Immunity to influenza in older adults with chronic obstructive pulmonary disease J Infect Dis 190 2004 11 19 [Epub 2004 May 26]
18. S.K. Bowles, W. Lee, and A.E. Simor Use of oseltamivir during influenza outbreaks in Ontario nursing homes, 1999-2000 J Am Geriatr Soc 50 2002 608 616
19. P.J. Drinka, P. Krause, L. Nest, S. Gravenstein, B. Goodman, and P. Shult Delays in the application of outbreak control prophylaxis for influenza A in a nursing home Infect Control Hosp Epidemiol 23 2002 600 603
20. Z. Hirji, S. O'Grady, and J. Bonham Utility of zanamivir for chemoprophylaxis of concomitant influenza A and B in a complex continuing care population Infect Control Hosp Epidemiol 23 2002 604 608
21. S. Gravenstein, P. Drinka, and E.H. Duthie Efficacy of an influenza hemagglutinin-diphtheria toxoid conjugate vaccine in elderly nursing home subjects during an influenza outbreak J Am Geriatr Soc 42 1994 245 251
22. D.M. Murasko, E.D. Bernstein, and E.M. Gardner Role of humoral and cell-mediated immunity in protection from influenza disease after immunization of healthy elderly Exp Gerontol 37 2002 427 439
23. M.C. Zambon, J.D. Stockton, J.P. Clewley, and D.M. Fleming Contribution of influenza and respiratory syncytial virus to community cases of influenza-like illness: an observational study Lancet 358 2001 1410 1416
24. S.H. Seo, R. Webby, and R.G. Webster No apoptotic deaths and different levels of inductions of inflammatory cytokines in alveolar macrophages infected with influenza viruses Virology 329 2004 270 279
25. P.J. Drinka, P. Krause, and L. Nest Clinical features of influenza a virus infection in older hospitalized persons J Am Geriatr Soc 51 2003 1184
26. M. Loeb Pneumonia in older persons Clin Infect Dis 37 2003 1335 1339 [Epub 2003 Oct 13]
27. E.A. Muller Influence of training and inactivity on muscle strength Arch Phys Med Rehab 51 1970 449
28. V.A. Convertino Exercise responses after inactivity H. Saunders J. Vernikos Inactivity: physiologic effects 1986 Academic Press Orlando
29. A.M. McBean, and P.L. Hebert New estimates of influenza-related pneumonia and influenza hospitalizations among the elderly Int J Infect Dis 8 2004 227 235
30. T.R. Cate Clinical manifestations and consequences of influenza Am J Med 82 1987 15 19
31. P. Haber, F. DeStefano, and F.J. Angulo Guillain-Barre syndrome following influenza vaccination JAMA 292 2004 2478 2481
32. L. Kaiser, R.S. Fritz, S.E. Straus, L. Gubareva, and F.G. Hayden Symptom pathogenesis during acute influenza: interleukin-6 and other cytokine responses J Med Virol 64 2001 262 268
33. H. Achdout, T.I. Arnon, and G. Markel Enhanced recognition of human NK receptors after influenza virus infection J Immunol 171 2003 915 123
34. J.L. Virelizier, R. Postlethwaite, G.C. Schild, and A.C. Allison Antibody responses to antigenic determinants of influenza virus hemagglutinin. I. Thymus dependence of antibody formation and thymus independence of immunological memory J Exp Med 140 1974 1559 1570
35. I.A. de Bruijn, E.J. Remarque, C.M. Jol-van der Zijde, M.J. van Tol, R.G. Westendorp, and D.L. Knook Quality and quantity of the humoral immune response in healthy elderly and young subjects after annually repeated influenza vaccination J Infect Dis 179 1999 31 36
36. R.B. Effros, P.C. Doherty, W. Gerhard, and J. Bennink Generation of both cross-reactive and virus-specific T-cell populations after immunization with serologically distinct influenza A viruses J Exp Med 145 1977 557 568
37. G.M. Butchko, R.B. Armstrong, and F.A. Ennis Specificity studies on the proliferative response of thymus-derived lymphocytes to influenza viruses J Immunol 121 1978 2381 2385
38. S.M. Russell, and F.Y. Liew T cells primed by influenza virion internal components can cooperate in the antibody response to haemagglutinin Nature 280 1979 147 148
39. D.M. Mitchell, and R.E. Callard Fine specificity of the in vitro antibody response to influenza virus by human blood lymphocytes J Immunol 131 1983 1229 1233
40. B. Benacerraf Role of MHC gene products in immune regulation Science 212 1981 1229 1238
41. J.M. Lund, L. Alexopoulou, and A. Sato Recognition of single-stranded RNA viruses by Toll-like receptor 7 Proc Natl Acad Sci USA 101 2004 5598 5603 [Epub 2004 March 19]
42. F.A. Ennis, Q. Yi-Hua, and G.C. Schild Antibody and cytotoxic T lymphocyte responses of humans to live and inactivated influenza vaccines J Gen Virol 58 1982 273 281
43. A.J. McMichael, F.M. Gotch, G.R. Noble, and P.A. Beare Cytotoxic T-cell immunity to influenza N Engl J Med 309 1983 13 17
44. J.W. Yewdell, J.R. Bennink, and Y. Hosaka Cells process exogenous proteins for recognition by cytotoxic T lymphocytes Science 239 1988 637 640
45. C.J. Hackett, and L.C. Eisenlohr Virus entry and antigen biosynthesis in the processing and presentation of class-II MHC-restricted T-cell determinants of influenza virus Immunol Res 9 1990 103 114
46. M.E. Sanders, M.W. Makgoba, and S.O. Sharrow Human memory T lymphocytes express increased levels of three cell adhesion molecules (LFA-3, CD2, and LFA-1) and three other molecules (UCHL1, CDw29, and Pgp-1) and have enhanced IFN-gamma production J Immunol 140 1988 1401 1407
47. T.R. Mosmann, H. Cherwinski, M.W. Bond, M.A. Giedlin, and R.L. Coffman Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins J Immunol 136 1986 2348 2357
48. C.S. Hsieh, S.E. Macatonia, C.S. Tripp, S.F. Wolf, A. O'Garra, and K.M. Murphy Development of TH1 CD4+ T cells through IL-12 produced by Listeria- induced macrophages [see comments] Science 260 1993 547 549
49. P. Vieira, R. de Waal-Malefyt, and M.N. Dang Isolation and expression of human cytokine synthesis inhibitory factor cDNA clones: homology to Epstein-Barr virus open reading frame BCRFI Proc Natl Acad Sci USA 88 1991 1172 1176
50. K. Taga, and G. Tosato IL-10 inhibits human T cell proliferation and IL-2 production J Immunol 148 1992 1143 1148
51. N.S. Williams, and V.H. Engelhard Perforin-dependent cytotoxic activity and lymphokine secretion by CD4+ T cells are regulated by CD8+ T cells J Immunol 159 1997 2091 2099
52. P.A. Scherle, and W. Gerhard Differential ability of B cells specific for external vs. internal influenza virus proteins to respond to help from influenza virus- specific T-cell clones in vivo Proc Natl Acad Sci USA 85 1988 4446 4450
53. G. Palladino, P.A. Scherle, and W. Gerhard Activity of CD4+ T-cell clones of type 1 and type 2 in generation of influenza virus-specific cytotoxic responses in vitro J Virol 65 1991 6071 6076
54. F.A. Ennis, A.H. Rook, and Y.H. Qi HLA restricted virus-specific cytotoxic T-lymphocyte responses to live and inactivated influenza vaccines Lancet 2 1981 887 891
55. S. Demotz, H.M. Grey, and A. Sette The minimal number of class II MHC-antigen complexes needed for T cell activation Science 249 1990 1028 1030
56. C.J. Hackett, J.W. Yewdell, J.R. Bennink, and M. Wysocka Class II MHC-restricted T cell determinants processed from either endosomes or the cytosol show similar requirements for host protein transport but different kinetics of presentation J Immunol 146 1991 2944 2951
57. C.A. Lamb, J.W. Yewdell, J.R. Bennink, and P. Cresswell Invariant chain targets HLA class II molecules to acidic endosomes containing internalized influenza virus Proc Natl Acad Sci USA 88 1991 5998 6002
58. B.A. Askonas, A. Mullbacher, and R.B. Ashman Cytotoxic T-memory cells in virus infection and the specificity of helper T cells Immunology 45 1982 79 84
59. A. Huckriede, L. Bungener, and T. Stegmann The virosome concept for influenza vaccines Vaccine 23S1 2005 S1/26 S1/38
60. S.R. Gottesman, R.L. Walford, and G.J. Thorbecke Proliferative and cytotoxic immune functions in aging mice. III. Exogenous interleukin-2 rich supernatant only partially restores alloreactivity in vitro Mech Ageing Dev 31 1985 103 113
61. G.W. Canonica, G. Ciprandi, and M. Caria Defect of autologous mixed lymphocyte reaction and interleukin-2 in aged individuals Mech Ageing Dev 32 1985 205 212
62. S.E. Wiedmeier, B.A. Araneo, K. Huang, and R.A. Daynes Thymic modulation of IL-2 and IL-4 synthesis by peripheral T cells Cell Immunol 135 1991 501 518
63. E.T. Bloom, L.F. Kubota, and K. Kawakami Age-related decline in the lethal hit but not the binding stage of cytotoxic T-cell activity in mice Cell Immunol 114 1988 440 446
64. E.T. Bloom, H. Umehara, R.C. Bleackley, K. Okumura, H. Mostowski, and J.T. Babbitt Age-related decrement in cytotoxic T lymphocyte (CTL) activity is associated with decreased levels of mRNA encoded by two CTL-associated serine esterase genes and the perforin gene in mice Eur J Immunol 20 1990 2309 2316
65. D.C. Powers, and R.B. Belshe Effect of age on cytotoxic T lymphocyte memory as well as serum and local antibody responses elicited by inactivated influenza virus vaccine J Infect Dis 167 1993 584 592
66. S. Castle, K. Uyemura, W. Wong, R. Modlin, and R. Effros Evidence of enhanced type 2 immune response and impaired upregulation of a type 1 response in frail elderly nursing home residents Mech Ageing Dev 94 1997 7 16
67. S.F. Taylor, R.J. Cottey, D.S. Zander, and B.S. Bender Influenza infection of beta 2-microglobulin-deficient (beta 2 m-/-) mice reveals a loss of CD4+ T cell functions with aging J Immunol 159 1997 3453 3459
68. K.F. van der Sluijs, L.J. van Elden, and M. Nijhuis IL-10 is an important mediator of the enhanced susceptibility to pneumococcal pneumonia after influenza infection J Immunol 172 2004 7603 7609
69. K.C. Meyer The role of immunity in susceptibility to respiratory infection in the aging lung Respir Physiol 128 2001 23 31
70. N. Baumgarth, L. Brown, D. Jackson, and A. Kelso Novel features of the respiratory tract T-cell response to influenza virus infection: lung T cells increase expression of gamma interferon mRNA in vivo and maintain high levels of mRNA expression for interleukin-5 (IL-5) and IL-10 J Virol 68 1994 7575 7581
71. A. Bot, K.A. Smith, and M. von Herrath Molecular and cellular control of T1/T2 immunity at the interface between antimicrobial defense and immune pathology DNA Cell Biol 23 2004 341 350
72. M. Renshaw, J. Rockwell, C. Engleman, A. Gewirtz, J. Katz, and S. Sambhara Cutting edge: impaired Toll-like receptor expression and function in aging J Immunol 169 2002 4697 4701
73. L. Haynes, S.M. Eaton, E.M. Burns, M. Rincon, and S.L. Swain Inflammatory cytokines overcome age-related defects in CD4 T cell responses in vivo J Immunol 172 2004 5194 5199
74. R. Glaser, T.F. Robles, J. Sheridan, W.B. Malarkey, and J.K. Kiecolt-Glaser Mild depressive symptoms are associated with amplified and prolonged inflammatory responses after influenza virus vaccination in older adults Arch Gen Psychiatry 60 2003 1009 1014
75. J.E. McElhaney, G.S. Meneilly, and B.L. Beattie The effect of influenza vaccination on IL2 production in healthy elderly: implications for current vaccination practices J Gerontol 47 1992 M3 M8
76. J.E. McElhaney, G.S. Meneilly, K.E. Lechelt, and R.C. Bleackley Split-virus influenza vaccines: do they provide adequate immunity in the elderly? J Gerontol 49 1994 M37 M43
77. J.E. McElhaney, G.S. Meneilly, M.J. Pinkoski, K.E. Lechelt, and R.C. Bleackley Vaccine-related determinants of the interleukin-2 response to influenza vaccination in healthy young and elderly adults Vaccine 13 1995 6 10
78. J.E. McElhaney, S. Gravenstein, C.M. Upshaw, J.W. Hooton, P. Krause, and P. Drinka Immune response to influenza vaccination in institutionalized elderly: effect on different T-cell subsets Vaccine 16 1998 403 409
79. J.E. McElhaney, C.M. Upshaw, J.W. Hooton, K.E. Lechelt, and G.S. Meneilly Responses to influenza vaccination in different T-cell subsets: a comparison of healthy young and older adults Vaccine 16 1998 1742 1747
80. E. Bernstein, D. Kaye, E. Abrutyn, P. Gross, M. Dorfman, and D.M. Murasko Immune response to influenza vaccination in a large healthy elderly population Vaccine 17 1999 82 94
81. J.E. McElhaney, S. Gravenstein, C. Upshaw, J. Hooton, P. Krause, and P. Drinka Granzyme B response to influenza vaccination: a marker of risk for influenza in institutionalized older adults Vaccine 19 2001 3744 3751
82. J.E. McElhaney, J.M. Herre, M.L. Lawson, S.K. Cole, B.L. Burke, and J.W. Hooton Effect of congestive heart failure on humoral and ex vivo cellular immune responses to influenza vaccination in older adults Vaccine 22 2004 681 688
83. J.E. McElhaney, J.W. Hooton, N. Hooton, and R.C. Bleackley Effect of booster versus single dose influenza vaccination on humoral and cellular immune responses Vaccine 23 2005 3294 3300
84. H.H. Nguyen, Z. Moldoveanu, and M.J. Novak Heterosubtypic immunity to lethal influenza A virus infection is associated with virus-specific CD8(+) cytotoxic T lymphocyte responses induced in mucosa-associated tissues Virology 254 1999 50 60
85. S.J. Ray, S.N. Franki, and R.H. Pierce The collagen binding alpha1beta1 integrin VLA-1 regulates CD8 T cell-mediated immune protection against heterologous influenza infection Immunity 20 2004 167 179
86. S. Liang, K. Mozdzanowska, G. Palladino, and W. Gerhard Heterosubtypic immunity to influenza type A virus in mice. Effector mechanisms and their longevity J Immunol 152 1994 1653 1661
87. K.L. Yap, and G.L. Ada The recovery of mice from influenza A virus infection: adoptive transfer of immunity with influenza virus-specific cytotoxic T lymphocytes recognizing a common virion antigen Scand J Immunol 8 1978 413 420
88. K.L. Yap, T.J. Braciale, and G.L. Ada Role of T-cell function in recovery from murine influenza infection Cell Immunol 43 1979 341 351
89. K.L. Yap, and G.L. Ada The effect of specific antibody on the generation of cytotoxic T lymphocytes and the recovery of mice from influenza virus infection Scand J Immunol 10 1979 325 332
90. M.S. Pasternack, and H.N. Eisen A novel serine esterase expressed by cytotoxic T lymphocytes Nature 314 1985 743 745
91. R.C. Bleackley, C.G. Lobe, and B. Duggan The isolation and characterization of a family of serine protease genes expressed in activated cytotoxic T lymphocytes Immunol Rev 103 1988 5 19
92. D.E. Jenne, and J. Tschopp Granzymes, a family of serine proteases released from granules of cytolytic T lymphocytes upon T cell receptor stimulation Immunol Rev 103 1988 53 71
93. T. Ito, O.T. Gorman, Y. Kawaoka, W.J. Bean, and R.G. Webster Evolutionary analysis of the influenza A virus M gene with comparison of the M1 and M2 proteins J Virol 65 1991 5491 5498
94. E. Rouvier, M.F. Luciani, and P. Golstein Fas involvement in Ca(2+)-independent T cell-mediated cytotoxicity J Exp Med 177 1993 195 200
95. P.C. Doherty, D.J. Topham, R.A. Tripp, R.D. Cardin, J.W. Brooks, and P.G. Stevenson Effector CD4+ and CD8+ T-cell mechanisms in the control of respiratory virus infections Immunol Rev 159 1997 105 117
96. A.J. Darmon, D.W. Nicholson, and R.C. Bleackley Activation of the apoptotic protease CPP32 by cytotoxic T-cell-derived granzyme B Nature 377 1995 446 448
97. D. Kagi, B. Ledermann, and K. Burki Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice [see comments] Nature 369 1994 31 37
98. J.E. McElhaney, M.J. Pinkoski, C.M. Upshaw, and R.C. Bleackley The cell-mediated cytotoxic response to influenza vaccination using an assay for granzyme B activity J Immunol Methods 190 1996 11 20
99. C. Ewen, K.P. Kane, and I. Shostak A novel cytotoxicity assay to evaluate antigen-specific CTL responses using a colorimetric substrate for Granzyme B J Immunol Methods 276 2003 89 101
100. M.M. Simon, M. Hausmann, and T. Tran In vitro- and ex vivo-derived cytolytic leukocytes from granzyme A × B double knockout mice are defective in granule-mediated apoptosis but not lysis of target cells J Exp Med 186 1997 1781 1786
101. B.J. Johnson, E.O. Costelloe, and D.R. Fitzpatrick Single-cell perforin and granzyme expression reveals the anatomical localization of effector CD8+ T cells in influenza virus-infected mice Proc Natl Acad Sci USA 100 2003 2657 2662 [Epub 2003 Feb 24.]
102. J.E. McElhaney, M.J. Pinkoski, C.M. Upshaw, and R.C. Bleackley The cell-mediated cytotoxic response to influenza vaccination using an assay for granzyme B activity J Immunol Methods 190 1996 11 20
103. B.S. Bender, S.F. Taylor, D.S. Zander, and R. Cottey Pulmonary immune response of young and aged mice after influenza challenge J Lab Clin Med 126 1995 169 177
104. B.S. Bender, and P.A. Small Jr Heterotypic immune mice lose protection against influenza virus infection with senescence J Infect Dis 168 1993 873 880
105. Y. Hosaka, F. Sasao, K. Yamanaka, J.R. Bennink, and J.W. Yewdell Recognition of noninfectious influenza virus by class I-restricted murine cytotoxic T lymphocytes J Immunol 140 1988 606 610
106. G.J. Gorse, and R.B. Belshe Enhancement of anti-influenza A virus cytotoxicity following influenza A virus vaccination in older, chronically ill adults J Clin Microbiol 28 1990 2539 2550
107. D.C. Powers Influenza A virus-specific cytotoxic T lymphocyte activity declines with advancing age [see comments] J Am Geriatr Soc 41 1993 1 5
108. I.N. Mbawuike, A.R. Lange, and R.B. Couch Diminished influenza A virus-specific MHC class I-restricted cytotoxic T lymphocyte activity among elderly persons Viral Immunol 6 1993 55 64
109. J.E. McElhaney, S. Gravenstein, P. Krause, J.W. Hooton, C.M. Upshaw, and P. Drinka Assessment of markers of the cell-mediated immune response after influenza virus infection in frail older adults Clin Diagn Lab Immunol 5 1998 840 844
110. D.C. Powers, and R.B. Belshe Effect of age on cytotoxic T lymphocyte memory as well as serum and local antibody responses elicited by inactivated influenza virus vaccine J Infect Dis 167 1993 584 592
111. J.E. McElhaney, S. Gravenstein, and C.M. Upshaw Granzyme B: a marker of risk for influenza in institutionalized older adults Vaccine 19 2001 3744 3751
112. I. Kang, M.S. Hong, and H. Nolasco Age-associated change in the frequency of memory CD4+ T cells impairs long term CD4+ T cell responses to influenza vaccine J Immunol 173 2004 673 681
113. C. Franceschi, D. Monti, P. Sansoni, and A. Cossarizza The immunology of exceptional individuals: the lesson of centenarians Immunol Today 16 1995 12 16
114. F.G. Ferguson, A. Wikby, P. Maxson, J. Olsson, and B. Johansson Immune parametes in a longitudinal study of a very old poplulation of Swedish people: a comparison between survivors and non-survivors J Gerontol A Biol Sci Med Sci 50 1995 B378 B382
115. R.B. Effros Loss of CD28 expression on T lymphocytes: a marker of replicative senescence Dev Comp Immunol 21 1997 471 478
116. R.B. Effros, M. Dagarag, and H.F. Valenzuela In vitro senescence of immune cells Exp Gerontol 38 2003 1243 1249
117. R.B. Effros, N. Boucher, and V. Porter Decline in CD28+ T cells in centenarians and in long-term T cell cultures: a possible cause for both in vivo and in vitro immunosenescence Exp Gerontol 29 1994 601 609
118. C.R. Engwerda, B.S. Handwerger, and B.S. Fox Aged T cells are hyporesponsive to costimulation mediated by CD28 J Immunol 152 1994 3740 3747
119. R.B. Effros Genetic alterations in the ageing immune system: impact on infection and cancer Mech Ageing Dev 124 2003 71 77
120. J.J. Goronzy, J.W. Fulbright, C.S. Crowson, G.A. Poland, W.M. O'Fallon, and C.M. Weyand Value of immunological markers in predicting responsiveness to influenza vaccination in elderly individuals J Virol 75 2001 12182 12187
121. M. Saurwein-Teissl, T.L. Lung, and F. Marx Lack of antibody production following immunization in old age: association with CD8(+)CD28(-) T cell clonal expansions and an imbalance in the production of Th1 and Th2 cytokines J Immunol 168 2002 5893 5899
122. G. Pawelec Hypothesis: loss of telomerase inducibility and subsequent replicative senescence in cultured human T cells is a result of altered costimulation Mech Ageing Dev 121 2000 181 185
123. R.B. Effros Costimulatory mechanisms in the elderly Vaccine 18 2000 1661 1665
124. N. Boucher, T. Dufeu-Duchesne, E. Vicaut, D. Farge, R.B. Effros, and F. Schachter CD28 expression in T cell aging and human longevity Exp Gerontol 33 1998 267 282
125. D.N. Posnett, J.W. Edinger, J.S. Manavalan, C. Irwin, and G. Marodon Differentiation of human CD8 T cells: implications for in vivo persistence of CD8+ CD28- cytotoxic effector clones Int Immunol 11 1999 229 241
126. R.B. Effros Insights on immunological aging derived from the T lymphocyte cellular senescence model Exp Gerontol 31 1996 21 27
127. A.C. Boon, E. Fringuelli, and Y.M. Graus Influenza A virus specific T cell immunity in humans during aging Virology 299 2002 100 108
128. C. Letter, S. Gravenstein, and J.E. McElhaney Influenza vaccination is less effective for stimulating a granzyme B response in older adults Elsevier Science B V Int Congr Series 1219 2001 713 721
129. N.J. Borthwick, M. Lowdell, M. Salmon, and A.N. Akbar Loss of CD28 expression on CD8(+) T cells is induced by IL-2 receptor gamma chain signalling cytokines and type I IFN, and increases susceptibility to activation-induced apoptosis Int Immunol 12 2000 1005 1013
130. Z. Dai, A. Arakelov, M. Wagener, B.T. Konieczny, and F.G. Lakkis The role of the common cytokine receptor gamma-chain in regulating IL-2-dependent, activation-induced CD8+ T cell death J Immunol 163 1999 3131 3137
131. D.L. Wallace, Y. Zhang, and H. Ghattas Direct measurement of T cell subset kinetics in vivo in elderly men and women J Immunol 173 2004 1787 1794